BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain

The bromodomain protein, BRD4, has been identified recently as a therapeutic target in acute myeloid leukemia, multiple myeloma, Burkitt’s lymphoma, NUT midline carcinoma, colon cancer, and inflammatory disease; its loss is a prognostic signature for metastatic breast cancer. BRD4 also contributes t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Devaiah, Ballachanda N., Lewis, Brian A., Cherman, Natasha, Hewitt, Michael C., Albrecht, Brian K., Robey, Pamela G., Ozato, Keiko, Sims, Robert J., Singer, Dinah S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2012
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3345009/
https://ncbi.nlm.nih.gov/pubmed/22509028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1120422109
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak